Owner Dynavax Technologies Corporation

Inventors Fearon, Karen L.

Agent Davies Collison Cave

Pub. Number AU-B-2003302743

PCT Number PCT/US2003/0404

PCT Pub. Number WO2004/058159

Priority 60/436,406 23.12.02 US

Filing date 17 December 2003

Wipo publication date 22 July 2004

Acceptance publication date 4 September 2008

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids